BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32953353)

  • 1. Frequency of Neurological Presentations of Coronavirus Disease in Patients Presenting to a Tertiary Care Hospital During the 2019 Coronavirus Disease Pandemic.
    Iltaf S; Fatima M; Salman S; Salam JU; Abbas S
    Cureus; 2020 Aug; 12(8):e9846. PubMed ID: 32953353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological manifestations of COVID-19 and other coronaviruses: A systematic review.
    Correia AO; Feitosa PWG; Moreira JLS; Nogueira SÁR; Fonseca RB; Nobre MEP
    Neurol Psychiatry Brain Res; 2020 Sep; 37():27-32. PubMed ID: 32834527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noteworthy Neurological Manifestations Associated With COVID-19 Infection.
    Elkhouly A; Kaplan AC
    Cureus; 2020 Jul; 12(7):e8992. PubMed ID: 32775074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noteworthy Neurological Manifestations Associated With COVID-19 Infection.
    Kaplan AC
    Cureus; 2021 Apr; 13(4):e14391. PubMed ID: 33987051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Frequency of Neurological Symptoms in COVID-19 Patients at a Tertiary Care Hospital in Pakistan.
    Makda A; Kumar S; Kumar A; Kumar V; Rizwan A
    Cureus; 2020 Sep; 12(9):e10360. PubMed ID: 33062483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological Manifestations in Hospitalized Geriatric Patients With COVID-19 at King Abdulaziz Medical City in Jeddah, Western Region, Saudi Arabia From 2020 to 2021: A Cross-Sectional Study.
    Marghalani YO; Kaneetah AH; Khan MA; Albakistani AA; Alzahrani SG; Kidwai A; Alansari KW; Alhamid HS; Alharbi MH; Attar A
    Cureus; 2023 Sep; 15(9):e45759. PubMed ID: 37876390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and Neurology: An Emerging Association.
    Gupta A; Yadav P; Kumar D
    Infect Disord Drug Targets; 2021; 21(8):e160921191570. PubMed ID: 33602080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Retrospective Observational Study of Neurological Manifestations in COVID-19 (SON-CoV).
    Ramrakhiani N; Bhutani N; Chaudhary D; Parab P; Singh K; Agrawal P; Gupta V
    J Assoc Physicians India; 2022 Oct; 70(10):11-12. PubMed ID: 37355862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bifacial weakness with paresthesia – a rare Guillain–Barré syndrome subtype associated with SARS-CoV-2 infection].
    Gaál T; Szeszák G; Torák G; Salacz P
    Orv Hetil; 2021 Nov; 162(45):1803-1807. PubMed ID: 34747359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance Study of Acute Neurological Manifestations among 439 Egyptian Patients with COVID-19 in Assiut and Aswan University Hospitals.
    Khedr EM; Abo-Elfetoh N; Deaf E; Hassan HM; Amin MT; Soliman RK; Attia AA; Zarzour AA; Zain M; Mohamed-Hussein A; Hashem MK; Hassany SM; Aly A; Shoyb A; Saber M
    Neuroepidemiology; 2021; 55(2):109-118. PubMed ID: 33631765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
    Rogers JP; Chesney E; Oliver D; Pollak TA; McGuire P; Fusar-Poli P; Zandi MS; Lewis G; David AS
    Lancet Psychiatry; 2020 Jul; 7(7):611-627. PubMed ID: 32437679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurologic Compromise in COVID-19: A Literature Review.
    Jardim Vaz de Mello L; Guimaraes Silva E; Oliveira Correa Rabelo G; Evaristo Leite M; Vieira NR; Bahadori M; Seifi A; Godoy DA
    J Neurol Res; 2020 Oct; 10(5):164-172. PubMed ID: 33984100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study.
    Amanat M; Rezaei N; Roozbeh M; Shojaei M; Tafakhori A; Zoghi A; Darazam IA; Salehi M; Karimialavijeh E; Lima BS; Garakani A; Vaccaro A; Ramezani M
    BMC Neurol; 2021 Mar; 21(1):116. PubMed ID: 33726699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020.
    LaRovere KL; Poussaint TY; Young CC; Newhams MM; Kucukak S; Irby K; Kong M; Schwartz SP; Walker TC; Bembea MM; Wellnitz K; Havlin KM; Cvijanovich NZ; Hall MW; Fitzgerald JC; Schuster JE; Hobbs CV; Halasa NB; Singh AR; Mack EH; Bradford TT; Gertz SJ; Schwarz AJ; Typpo KV; Loftis LL; Giuliano JS; Horwitz SM; Biagas KV; Clouser KN; Rowan CM; Maddux AB; Soma VL; Babbitt CJ; Aguiar CL; Kolmar AR; Heidemann SM; Harvey H; Zambrano LD; Campbell AP; Randolph AG;
    JAMA Neurol; 2023 Jan; 80(1):91-98. PubMed ID: 36342679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological associations of COVID-19.
    Ellul MA; Benjamin L; Singh B; Lant S; Michael BD; Easton A; Kneen R; Defres S; Sejvar J; Solomon T
    Lancet Neurol; 2020 Sep; 19(9):767-783. PubMed ID: 32622375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the frequency of neurological symptoms in COVID-19 patients: A cross-sectional study.
    Rasouli S; Emami P; Azadmehr F; Karimyan F
    Health Sci Rep; 2023 Jul; 6(7):e1400. PubMed ID: 37492273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.